SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.
Justin T DenholmEmma S McBrydeDamon EisenAlan StreetElizabeth MatchettCaroline ChenThomas Ray ShultzBeverly BiggsKarin LederPublished in: Internal medicine journal (2018)
This study provides cost analysis evidence to support the use of 3HP for the treatment of LTBI in Australia.